AustinPx Invests in Pharmaceutics and Manufacturing Capabilities to Accelerate Drug Development
Elizabeth Hickman to Succeed Tim Scott as AustinPx CEO
AustinPx Partners with Microsize on KinetiSol® Technology
AustinPx Expands Development and Manufacturing Technologies
GEORGETOWN, Texas--(BUSINESS WIRE)--AustinPx, Pharmaceutics and Manufacturing, a contract development and manufacturing organization (CDMO), today announced the appointment of Derek Hennecke and Marshall Crew as independent members of its board of directors. Appointments provide additional experienced CDMO leadership to drive growth in the complex formulation and manufacturing market
GEORGETOWN, Texas--(BUSINESS WIRE)--AustinPx, Pharmaceutics and Manufacturing, a contract development and manufacturing organization (CDMO), today announced the appointment of Elizabeth Hickman as Chief Business Officer (CBO). In this role, Ms. Hickman will be responsible for the Company’s CDMO business operations and strategy, including building capabilities and a team to deliver high-value solutions for pharmaceutical customers.
GEORGETOWN, Texas--(BUSINESS WIRE)--DisperSol Technologies LLC announced today that it is has entered into a research collaboration with Ajax Therapeutics, Inc. to apply its KinetiSol technology to enhance the bioavailability of an Ajax drug candidate in development for the treatment of hematologic malignancies.
DisperSol Technologies, a clinical-stage pharmaceutical company developing new treatments for oncology and rare diseases, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced a strategic manufacturing collaboration to accelerate the development of multiple DisperSol pharmaceutical products. The collaboration will see the installation of a commercial-scale KinetiSol® technology manufacturing line at Catalent’s oral solids development and manufacturing facility in Somerset, New Jersey.
GEORGETOWN, Texas--(BUSINESS WIRE)--DisperSol Technologies LLC announced today that its Board of Directors has appointed David S. Snyder as its Chief Financial Officer effective October 1, 2020.